Tanvex Biopharma(TW:6541)
NT$28.150.00 (0.00%)
TW:6541
Tanvex Biopharma Revenue
NT$28.15
At close:0.00 (0.00%)
Want to see TW:6541 full AI Analyst Report?
Tanvex Biopharma (6541) Revenue
Tanvex Biopharma Revenue
Tanvex Biopharma had a revenue of 220.44M in the quarter ending Jun 30, 2026, with 65.96%. This bring the company's revenue in the last twelve months to 657.56M, Increased 35.88%. In the fiscal year ending Dec 31, 2025, Tanvex Biopharma had annual revenue of 400.97M with 1056.27% growth.
- Revenue (ttm)
- 657.56M
- Revenue Growth
- 207.37%
- P/S Ratio
- 18.62
- Revenue/Employee
- TWD 1,864,981
- Employees
- 215
- Market Cap
- TWD 7.47B
Revenue Chart
Tanvex Biopharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 400.97M | 366.29M | 1056.27% |
| Dec 31, 2024 | 34.68M | -26.73M | -43.53% |
| Dec 31, 2023 | 61.41M | 39.01M | 174.11% |
| Dec 31, 2022 | 22.40M | 17.00M | 314.43% |
| Dec 31, 2021 | 5.41M | 5.11M | 1702.00% |
| Dec 31, 2020 | 300.00K | 300.00K | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| TW:6541 | 657.56M |